Literature DB >> 2004382

Interphase cytogenetics of hematological cancer: comparison of classical karyotyping and in situ hybridization using a panel of eleven chromosome specific DNA probes.

P J Poddighe1, O Moesker, D Smeets, B H Awwad, F C Ramaekers, A H Hopman.   

Abstract

Numerical chromosome aberrations were detected in hematological cancers by nonradioactive in situ hybridization (ISH) procedures, using centromere specific probes for chromosomes 1, 7, 8, 9, 10, 11, 16, 17, 18, X, and Y. All 15 cases could be evaluated by ISH for these 11 probes. Our experiments show that in seven of these randomly selected leukemia bone marrow cell suspensions numerical aberrations for one or two chromosomes could be detected by this method. The results of ISH on interphase nuclei and in some cases on metaphase preparations were compared with karyotyping data. Seven cases of chromosomal aberrations observed with ISH (three for monosomy and four for trisomy) were confirmed by this classical cytogenetic technique, whereas in five instances an aberration was found only with ISH (twice for monosomy, twice for trisomy, and one disomy for the Y-probe). One case of a trisomy for chromosome 1 observed by ISH on interphase nuclei could be explained by a marker chromosome, a finding that was further substantiated by ISH on metaphase spreads. In this case double-target ISH on interphase cells with the probes for chromosomes 1 and 16 strongly suggested a translocation between these chromosomes. Also, in one case a marker chromosome could be characterized as a translocation between chromosomes 7 and 17. In this latter case the cytogenetic examinations revealed only monosomy for chromosomes 7 and 17 in addition to noncharacterized marker chromosomes. Our results indicate that the nonradioactive ISH procedure in combination with chromosome specific repetitive centromeric probes is a powerful tool for studying both numerical and structural chromosomal aberrations in interphase nuclei of leukemias. It may therefore become a valuable and routine diagnostic tool in addition to the existing karyotyping procedures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004382

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Reciprocal translocation between the proximal regions of the long arms of chromosomes 13 and 15 resulting in unbalanced offspring: characterization by fluorescence in situ hybridization and DNA analysis.

Authors:  K Mangelschots; B Van Roy; F Speleman; N Van Roy; J Gheuens; J Beuten; I Buntinx; M N Van Thienen; H Willekens; J Dumon
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

2.  Detection of minimal residual disease in leukaemia.

Authors:  F E Katz
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

3.  Rapid generation of chromosome-specific alphoid DNA probes using the polymerase chain reaction.

Authors:  I Dunham; C Lengauer; T Cremer; T Featherstone
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

4.  Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications.

Authors:  J M Davison; T W Morgan; B L Hsi; S Xiao; J A Fletcher
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

5.  Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinomas.

Authors:  J C Alers; P J Krijtenburg; K J Vissers; S K Krishnadath; F T Bosman; H van Dekken
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

6.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

7.  Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by densitometric analysis on (pre)-malignant cervical lesions.

Authors:  P Segers; S Haesen; P Castelain; J J Amy; P De Sutter; P Van Dam; M Kirsch-Volders
Journal:  Histochem J       Date:  1995-01

8.  An improved, non-isotopic method of screening cells from patients with abnormalities of sexual differentiation for Y chromosomal DNA content.

Authors:  M Witt; K Michalczak; A Latos-Bielenska; J Jaruzelska; I Kuczora; M Lopez
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

Review 9.  Detection of genomic changes in cancer by in situ hybridization.

Authors:  A H Hopman; C E Voorter; F C Ramaekers
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

10.  Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.

Authors:  K Dhingra; A Sahin; J Supak; S Y Kim; G Hortobagyi; W N Hittelman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.